Want to take quizzes and track your credits?
As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection spreads globally, dermatologists are recognizing a variety of cutaneous manifestations in patients with coronavirus disease 2019 (COVID-19). A recent Spanish report1 categorized skin findings in 375 patients with suspected and confirmed COVID-19, including livedoid and necrotic eruptions, which were noted in patients with more severe disease. The authors suggested that these skin manifestations may be associated with occlusive vascular disease.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
Accepted for Publication: June 1, 2020.
Published Online: August 5, 2020. doi:10.1001/jamadermatol.2020.2800
Correction: This article was corrected on September 23, 2020, to fix an error in the byline.
Corresponding Author: Joanna Harp, MD, Department of Dermatology, NewYork-Presbyterian/Weill Cornell Medical College, 1305 York Ave, 9th Floor, New York, NY 10021 (firstname.lastname@example.org).
Author Contributions: Drs Droesch and Harp had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Droesch, Magro, Harp.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Droesch, Do, Lee, Harp.
Critical revision of the manuscript for important intellectual content: Droesch, DeSancho, Lee, Magro, Harp.
Statistical analysis: Harp.
Administrative, technical, or material support: Magro, Harp.
Supervision: Magro, Harp.
Conflict of Interest Disclosures: Dr DeSancho reported serving on the Advisory Boards for Bio Products Laboratory and Sanofi-Genzyme. No other disclosures were reported.
You currently have no searches saved.